Solventum Corp | SOLV - Sales Revenues


Solventum Corp reported $2.2B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Align Technology USD 1.06B 20M Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Cencora USD 84.8B 1.13B Jun/2026
Dexcom USD 1.31B 120M Jun/2026
Insulet USD 801.7M 40M Jun/2026
Solventum Corp USD 2.2B 190M Jun/2026
West Pharmaceutical Services USD 872.3M 27.4M Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026